カテゴリ： MarketLine, 企業調査, 日本

Nippon Life Insurance Company：戦略・SWOT・企業財務分析

◆英語タイトル：Nippon Life Insurance Company - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015596
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：42
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：金融サービス
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Nippon Life Insurance Company – Strategy, SWOT and Corporate Finance Report
Summary

Nippon Life Insurance Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Nippon Life Insurance Company (Nippon or ‘the company’) is one of the leading life insurance company, offering individual and group life and annuity products. The company’s other activities include real estate development, investment advisory services, trust and custody services, investment financing services, and overseas asset management services. Nippon operates in Japan, the US, the UK, and Asia. It is headquartered in Osaka, Japan.

Scope

- Detailed information on Nippon Life Insurance Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Nippon Life Insurance Company in the form of a SWOT analysis
- An in-depth view of the business model of Nippon Life Insurance Company including a breakdown and examination of key business segments
- Intelligence on Nippon Life Insurance Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Nippon Life Insurance Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Nippon Life Insurance Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Nippon Life Insurance Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Nippon Life Insurance Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Nippon Life Insurance Company: Company Overview
Nippon Life Insurance Company: Overview and Key Facts
Nippon Life Insurance Company: Overview
Nippon Life Insurance Company: Key Facts
Nippon Life Insurance Company: Key Employees
Nippon Life Insurance Company: Major Products and Services
Nippon Life Insurance Company: Company History
Nippon Life Insurance Company: Management Statement
Nippon Life Insurance Company: Locations and Subsidiaries
Nippon Life Insurance Company: Key Competitors
Nippon Life Insurance Company: Company Analysis
Nippon Life Insurance Company: Business Description
Nippon Life Insurance Company: SWOT Analysis
Nippon Life Insurance Company: SWOT Overview
Nippon Life Insurance Company: Strengths
Nippon Life Insurance Company: Weaknesses
Nippon Life Insurance Company: Opportunities
Nippon Life Insurance Company: Threats
Nippon Life Insurance Company: Corporate Financial Deals Activity
Nippon Life Insurance Company: Financial Deals Overview
Nippon Life Insurance Company: Targets and Partners
Nippon Life Insurance Company: Top Deals 2013 – 2017YTD*
Nippon Life Insurance Company: Advisors
Nippon Life Insurance Company: Top Financial Advisors
Nippon Life Insurance Company: Mergers and Acquisitions
Nippon Life Insurance Company: Corporate Venturing
Nippon Life Insurance Company: Capital Raising
Nippon Life Insurance Company: Recent Developments
Nippon Life Insurance Company: News and Events Summary
Nippon Life Insurance Company: Financial Performance
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Nippon Life Insurance Company: Key Facts
Table 2: Nippon Life Insurance Company: Key Employees
Table 3: Nippon Life Insurance Company: Locations and Subsidiaries
Table 4: Nippon Life Insurance Company: Key Competitors
Table 5: Nippon Life Insurance Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Nippon Life Insurance Company: M&A Activity by Geography (TTM*)
Table 7: Nippon Life Insurance Company: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: Nippon Life Insurance Company: M&A Average Deal Size - Value (US$m)
Table 9: Nippon Life Insurance Company: Targets and Partners
Table 10: Nippon Life Insurance Company: Top Deals 2013 - 2017YTD*
Table 11: Nippon Life Insurance Company: Financial Advisor Ranking by Value (US$m)
Table 12: Nippon Life Insurance Company: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: Nippon Life Insurance Company: M&A Activity by Geography (2013 - YTD*2017)
Table 14: Nippon Life Insurance Company: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 15: Nippon Life Insurance Company: Corporate Venturing by Geography (2013 - YTD*2017)
Table 16: Nippon Life Insurance Company: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 17: Nippon Life Insurance Company: Capital Raising by Deal Type (2013 - YTD*2017)
Table 18: Nippon Life Insurance Company: News and Events Summary
Table 19: Nippon Life Insurance Company: Financial Performance

★海外企業調査レポート[Nippon Life Insurance Company：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Martinrea International Inc.：戦略・SWOT・企業財務分析
    Martinrea International Inc. - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Equinix Inc (EQIX)：企業の財務・戦略的SWOT分析
    Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • WSI Industries, Inc.：企業の戦略・SWOT・財務情報
    WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Axcelis Technologies Inc (ACLS)：企業の財務・戦略的SWOT分析
    Summary Axcelis Technologies Inc (Axcelis) operates as a technology company that provides industrial equipment and services for semiconductor industries. The company’s offers ion implantation product, which include high current implanters, purion H, optima HDx, high energy purion XE, optima XEx, par …
  • Vertu Motors Plc：企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Cleveland BioLabs Inc (CBLI)：企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a bio pharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …
  • Reliance Communications Limited：企業の戦略・SWOT・財務情報
    Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Boardriders, Inc：企業の戦略的SWOT分析
    Boardriders, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • MBNA Ltd：企業の戦略・SWOT・財務情報
    MBNA Ltd - Strategy, SWOT and Corporate Finance Report Summary MBNA Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • University of California Berkeley-製薬・医療分野：企業M&A・提携分析
    Summary University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and tra …
  • Lebara Group：企業の戦略的SWOT分析
    Lebara Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • International Vaccine Institute：製薬・医療：M&Aディール及び事業提携情報
    Summary International Vaccine Institute (IVI) is a non-profit organization that discovers, develops and delivers vaccines. The organization's vaccines include bivalent inactivated oral cholera vaccine, Vi-DT typhoid conjugate vaccine, bivalent typhoid conjugate vaccine, shigella vaccine, norovirus v …
  • Printpack Inc：企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cosmo Pharmaceuticals NV (COPN)：医療機器：M&Aディール及び事業提携情報
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Viking Therapeutics Inc (VKTX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. The company’s lead clinical program product candidate include VK5211, an orally available, non-steroidal se …
  • Gammon India Ltd (GAMMONIND)：企業の財務・戦略的SWOT分析
    Gammon India Ltd (GAMMONIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Galliford Try Holdings Plc (GFRD)：企業の財務・戦略的SWOT分析
    Galliford Try Holdings Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • VidaCaixa, S.A.U. de Seguros y Reaseguros：企業の戦略・SWOT・財務情報
    VidaCaixa, S.A.U. de Seguros y Reaseguros - Strategy, SWOT and Corporate Finance Report Summary VidaCaixa, S.A.U. de Seguros y Reaseguros - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Hybrigenics SA (ALHYG)：製薬・医療：M&Aディール及び事業提携情報
    Summary Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases. Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being assessed for various cancer indications including prostate cance …
  • ISS AS：企業のM&A・事業提携・投資動向
    ISS AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ISS AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆